The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease

Alzheimer's Research and Therapy

Volumn 6, Issue 3, 2014, Pages

  Jochemsen, Hadassa M ^a,b   Teunissen, Charlotte E ^a   Ashby, Emma L ^c   Van Der Flier, Wiesje M ^a   Jones, Ruth E ^c   Geerlings, Mirjam I ^b   Scheltens, Philip ^a   Kehoe, Patrick G ^c   Muller, Majon ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TAU PROTEIN; THREONINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; PATIENT; PRIORITY JOURNAL; SERUM;

EID: 84903273400     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt257     Document Type: Article

References (33)

1. Alzheimer's disease. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E, Lancet 2011 377 1019 1031 10.1016/S0140-6736(10)61349-9 21371747
2. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. Rigat B, Hubert C, Henc-Gelas F, Cambien F, Corvol P, Soubrier F, J Clin Invest 1990 86 1343 1346 10.1172/JCI114844 1976655 (Pubitemid 20370444)
3. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Lehmann DJ, Cortina-Borja M, Warden DR, Smith AD, Sleegers K, Prince JA, van Duijn CM, Kehoe PG, Am J Epidemiol 2005 162 305 317 10.1093/aje/kwi202 16033878 (Pubitemid 41389712)
4. Alzheimer disease risk and genetic variation in ACE: a meta-analysis. Elkins JS, Douglas VC, Johnston SC, Neurology 2004 62 363 368 10.1212/01.WNL.0000106823.72493.FF 14872014 (Pubitemid 38200844)
5. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease. Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Nat Genet 2009 41 192 198 10.1038/ng.305 19136949
6. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, Fornazzari L, Gauthier S, Goodgame N, Guzman D, Hammond S, Hollingworth P, Hsiung GY, Johnson J, Kelly DD, Keren R, Kertesz A, King KS, Lovestone S, Loy-Englisch I, Matthews PM, et al. Arch Neurol 2008 65 45 53 17998437
7. A multi-center study of ACE and the risk of late-onset Alzheimer's disease. Belbin O, Brown K, Shi H, Medway C, Abraham R, Passmore P, Mann D, Smith AD, Holmes C, McGuinness B, Craig D, Warden D, Heun R, Kölsch H, Love S, Kalsheker N, Williams J, Owen MJ, Carresquillo M, Younkin S, Morgan K, Kehoe PG, J Alzheimers Dis 2011 24 587 597 21297258
8. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. Hemming ML, Selkoe DJ, J Biol Chem 2005 280 37644 37650 10.1074/jbc.M508460200 16154999 (Pubitemid 41642372)
9. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (Aβ); retards Aβ aggregation, deposition, fibril formation; and inhibits cytotoxicity. Hu J, Igarashi A, Kamata M, Nakagawa H, J Biol Chem 2001 276 47863 47868 11604391
10. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide. Oba R, Igarashi A, Kamata M, Nagata K, Takano S, Nakagawa H, Eur J Neurosci 2005 21 733 740 10.1111/j.1460-9568.2005. 03912.x 15733091 (Pubitemid 40363508)
11. Angiotensins in Alzheimer's disease-friend or foe? Kehoe PG, Miners S, Love S, Trends Neurosci 2009 32 619 628 10.1016/j.tins.2009.07.006 19796831
12. The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis? Kehoe PG, Passmore PA, J Alzheimers Dis 2012 30 251 S268 22330821
13. Haplotypes extending across ACE are associated with Alzheimer's disease. Kehoe PG, Katzov H, Feuk L, Bennet AM, Johansson B, Wiman B, de Faire U, Cairns NJ, Wilcock GK, Brookes AJ, Blennow K, Prince JA, Hum Mol Genet 2003 12 859 867 10.1093/hmg/ddg094 12668609 (Pubitemid 36504028)
14. Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM, Neurogenetics 2009 10 13 17 10.1007/s10048-008-0150-4 18813964
15. The effects of ramipril in individuals at risk for alzheimer's disease: results of a pilot clinical trial. Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Dowling M, Ye S, Gleason CE, Underbakke G, Jacobson LE, Johnson LE, Johnson SC, Sager MA, Asthana S, Carlsson CM, J Alzheimers Dis 2012 32 147 156 22776970
16. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension. Gillies LK, Werstiuk ES, Lee RM, J Hypertens 1998 16 477 486 10.1097/00004872-199816040-00009 9797193 (Pubitemid 28195857)
17. Brain renin-angiotensin-a new look at an old system. Wright JW, Harding JW, Prog Neurobiol 2011 95 49 67 10.1016/j.pneurobio.2011.07.001 21777652
18. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 939 944 10.1212/WNL.34.7.939 6610841 (Pubitemid 14076461)
19. Serum angiotensin-converting enzyme and recurrent vascular events. The SMART-MR study. Jochemsen HM, Geerlings MI, Visseren FL, Algra A, van der Graaf Y, Muller M, Atherosclerosis 2012 224 486 491 10.1016/j.atherosclerosis.2012.07. 010 22884917
20. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, Franciotta D, Frederiksen JL, Fleming JO, Furlan R, Hintzen RQ, Hughes SG, Johnson MH, Krasulova E, Kuhle J, Magnone MC, Raida C, Rejdak K, Schmidt HK, van Pesch V, Waubant E, Wolf C, Giovannoni G, Hemmer B, Tumani H, Deisenhammer F, Neurology 2009 73 1914 1922 10.1212/WNL. 0b013e3181c47cc2 19949037
21. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, Scheltens P, Blankenstein MA, Clin Chem 2010 56 248 253 10.1373/clinchem.2009.130518 19833838
22. Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, Prince JA, Love S, Kehoe PG, Am J Transl Res 2009 1 163 177 19956428
23. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, Kehoe PG, Neuropathol Appl Neurobiol 2008 34 181 193 10.1111/j.1365-2990.2007.00885.x 17973905 (Pubitemid 351327960)
24. Review: a gentle introduction to imputation of missing values. Donders AR, van der Heijden GJ, Stijnen T, Moons KG, J Clin Epidemiol 2006 59 1087 1091 10.1016/j.jclinepi.2006.01.014 16980149 (Pubitemid 44374314)
25. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. Van der Heijden GJ, Donders AR, Stijnen T, Moons KG, J Clin Epidemiol 2006 59 1102 1109 10.1016/j.jclinepi.2006.01.015 16980151 (Pubitemid 44374315)
26. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Lendon CL, Thaker U, Harris JM, McDonagh AM, Lambert JC, Chartier-Harlin MC, Iwatsubo T, Pickering-Brown SM, Mann DM, Neurosci Lett 2002 328 314 318 10.1016/S0304-3940(02)00553-0 12147333 (Pubitemid 34876673)
27. ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. Sleegers K, den Heijer T, van Dijk EJ, Hofman A, Bertoli-Avella AM, Koudstaal PJ, Breteler MM, van Duijn CM, Neurobiol Aging 2005 26 1153 1159 10.1016/j.neurobiolaging.2004.09.011 15917098 (Pubitemid 40726007)
28. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy-the SMART-MR study. Jochemsen HM, Geerlings MI, Grool AM, Vincken KL, Mali WP, van der Graaf Y, Muller M, J Alzheimers Dis 2012 29 39 49 22214784
29. Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains. Tian M, Zhu D, Xie W, Shi J, FEBS Lett 2012 586 3737 3745 10.1016/j.febslet.2012.09.004 22982863
30. Aβ42-to-Aβ40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme. Zou K, Maeda T, Watanabe A, Liu J, Liu S, Oba R, Satoh Y, Komano H, Michikawa M, J Biol Chem 2009 284 31914 31920 10.1074/jbc.M109.011437 19773553
31. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Kehoe PG, Wilcock GK, Lancet Neurol 2007 6 373 378 10.1016/S1474-4422(07)70077-7 17362841 (Pubitemid 46389616)
32. Associations of angiotensin targeting antihypertensive drugs with mortality and hospitalization in primary care patients with dementia. Kehoe PG, Davies NM, Martin RM, Ben Shlomo Y, J Alzheimers Dis 2012 33 999 1008
33. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B, BMJ 2010 340 5465 10.1136/bmj.b5465.:b5465 10.1136/bmj.b5465 20068258